Academics should use their intellectual property to produce cheap drugs for poor countriesBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39220.628692.DB (Published 24 May 2007) Cite this as: BMJ 2007;334:1079
- Geoff Watts
It is time to stop leaving the development of new drugs entirely to the marketplace, say two London academics. Universities should not only retain control over their intellectual property but use it for long term social goals rather than short term revenue, they say.
The physician Sunil Shaunak, of Imperial College London, and the chemist Steve Brocchini, of the School of Pharmacy, London, were speaking last week at a meeting of the House of Commons all-party pharmacy group.
Most drugs begin their life at high prices and under patent. In due …
Log in using your username and password
Log in through your institution
Sign up for a free trial